Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.
Gemina Labs has raised $2.1M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2026.
Gemina Labs's investors include Syniad Innovations.
Gemina Labs is headquartered in Vancouver, Canada.
Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.
Gemina Labs is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gemina Labs — Funding & Investors." VCBacked, July 13, 2026, https://www.vcbacked.co/company/gemina-labs. Accessed September 30, 2026.
VCBacked. (2026). Gemina Labs — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/gemina-labs
{{cite web |title=Gemina Labs — Funding & Investors |url=https://www.vcbacked.co/company/gemina-labs |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated